Physician profile
Karen E Bruce
NPI 1831298462
$1,449.58
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,227 · 2020: $177 · 2022: $14.96 · 2023: $30.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $261.99 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $181.49 | 2019-2023 | Farxiga |
| Amgen INC. | $117.32 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.41 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $102.06 | 2019-2020 | |
| Pfizer INC. | $81.57 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.56 | 2019-2020 | |
| Allergan, INC. | $63.85 | 2019-2020 | |
| Glaxosmithkline, LLC. | $62.32 | 2019-2020 | |
| Lilly USA, LLC | $58.44 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $54.38 | 2019-2020 | |
| Astellas Pharma US INC | $37.61 | 2019 | |
| Supernus Pharmaceuticals, INC. | $33.58 | 2019 | |
| Mylan Specialty L.P. | $26.50 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.12 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.60 | 2019 | |
| Genentech USA, INC. | $19.45 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.29 | 2019 | |
| Biogen, INC. | $16.33 | 2019 | |
| Celgene Corporation | $15.02 | 2019 | |
| Shionogi INC | $13.84 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.14 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.96 | 2019 | |
| Amarin Pharma, INC. | $12.22 | 2019 | |
| Collegium Pharmaceutical, INC. | $11.83 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.